Table 1 Patient characteristics and clinical outcome of HDI treated melanoma patients
Patient ID | Age (y) * | Gender | Clinical Response | Status at Follow-up | HDI Completed | Duration of Disease Free (mo) | Current status |
|---|---|---|---|---|---|---|---|
890 | 50 | M | CR | MET | Y, DR | 32 | Deceased |
901 | 62 | F | NR | MET | Y | 2 | Deceased |
903 | 45 | M | PR | NED | Y | 86 | Alive |
973 | 59 | M | PR | NED | Y | 54 | Alive |
974 | 70 | F | NR | NED | Y, DRx2 | 67 | Alive |
978 | 75 | M | PR | MET | Y | 12 | Deceased |
980 | 56 | F | NR | MET | Y, DRx2 | 6 | Deceased |
983 | 45 | M | NR | MET | Y | 6 | Deceased |
985 | 76 | F | PR | NED | Y, DR | 65 | Alive |
1006 | 78 | M | PR | MET | Y | 6 | Deceased |
1008 | 49 | M | PR | NED | Y, DR | 61 | Alive |
1015 | 57 | F | PR | MET | Y | 4 | Deceased |
1018 | 44 | M | PR | NED | Y | 60 | Alive |
1052 | 54 | M | NR | MET | Y | 19 | Alive |